ATAI Life Sciences's total assets for Q3 2024 were $197.52M, a decrease of -8.46% from the previous quarter. ATAI total liabilities were $51.20M for the fiscal quarter, a 8.38% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.